beatandraise : SEC Filings Research with AI

beatandraise.com

2.2.0.25falsefalse005450 - Disclosure - Earnings Per Share Attributable to Common Shareholders (Table)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 4/3/2011 USD ($) USD ($) / shares $Cur_3mos_20110403http://www.sec.gov/CIK0000078003duration2011-01-01T00:00:002011-04-03T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDperShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PercentStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0us-gaap_EarningsPerShareAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseEarnings Per Share Attributable to Common Shareholders [Abstract]3false0us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> Basic and diluted earnings per share (EPS) were computed using the following data: <div> <hr size="2" align="left" width="100%" style="COLOR: black"/> </div> </div> <div align="left"> <table width="100%" cellspacing="0" cellpadding="0" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td style="padding-bottom: 2px" valign="bottom">   </td> <td style="padding-bottom: 2px" valign="bottom">   </td> <td style="border-bottom: black 2px solid" valign="bottom" colspan="6"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="center"> Three Months Ended </div> </td> <td style="border-bottom: black 2px solid" valign="bottom" align="left">   </td> </tr> <tr> <td style="border-bottom: black 2px solid" valign="bottom" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> (millions) </div> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="right">   </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="right" colspan="2"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> April 3, </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> 2011 </div> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="left">   </td> <td style="text-indent: 0pt; margin-left: 0pt; padding-bottom: 2px; MARGIN-RIGHT: 0pt" valign="bottom" align="right">   </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="right" colspan="2"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> April 4, </div> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="right"> 2010 </div> </td> <td style="text-indent: 0pt; border-bottom: black 2px solid; margin-left: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" align="left">   </td> </tr> <tr> <td valign="bottom">   </td> <td valign="bottom">   </td> <td valign="bottom" colspan="2">   </td> <td valign="bottom" align="left">   </td> <td valign="bottom">   </td> <td valign="bottom" colspan="2">   </td> <td valign="bottom" align="left">   </td> </tr> <tr> <td valign="bottom" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> EPS Numerator––Basic: </div> </td> <td valign="bottom">   </td> <td valign="bottom" colspan="2">   </td> <td valign="bottom" align="left">   </td> <td valign="bottom">   </td> <td valign="bottom" colspan="2">   </td> <td valign="bottom" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Income from continuing operations </div> </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left"> $ </td> <td valign="bottom" width="9%" align="right"> 2,224 </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left"> $ </td> <td valign="bottom" width="9%" align="right"> 2,014 </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Less: Net income attributable to noncontrolling interests </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 12 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 9 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Income from continuing operations attributable to Pfizer Inc. </div> </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right"> 2,212 </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right"> 2,005 </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Less: Preferred stock dividends––net of tax </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> –– </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 1 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Income from continuing operations attributable to Pfizer Inc. common shareholders </div> </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right"> 2,212 </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right"> 2,004 </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Discontinued operations––net of tax </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 10 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 21 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 4px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Net income attributable to Pfizer Inc. common shareholders </div> </td> <td style="padding-bottom: 4px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> $ </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 2,222 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 4px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> $ </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 2,025 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> EPS Numerator––Diluted: </div> </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Income from continuing operations attributable to Pfizer Inc. common shareholders and </div> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left">  assumed conversions </div> </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left"> $ </td> <td valign="bottom" width="9%" align="right"> 2,212 </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left"> $ </td> <td valign="bottom" width="9%" align="right"> 2,005 </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> Discontinued operations––net of tax </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 10 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 21 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 4px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> Net income attributable to Pfizer Inc. common shareholders and assumed conversions </div> </td> <td style="padding-bottom: 4px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> $ </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 2,222 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 4px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left"> $ </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 2,026 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> EPS Denominator: </div> </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt" align="left"> Weighted-average number of common shares outstanding––Basic </div> </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right"> 7,982 </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right"> 8,061 </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 2px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Common-share equivalents: stock options, stock issuable under employee </div> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left">  compensation plans and convertible preferred stock </div> </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 53 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 2px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 2px solid" valign="bottom" width="9%" align="right"> 40 </td> <td style="border-bottom: black 2px solid" valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="padding-bottom: 4px" valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Weighted-average number of common shares outstanding––Diluted </div> </td> <td style="padding-bottom: 4px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 8,035 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="padding-bottom: 4px" valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 8,101 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td valign="bottom" width="76%">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="1%">   </td> <td valign="bottom" width="1%" align="left">   </td> <td valign="bottom" width="9%" align="right">   </td> <td valign="bottom" width="1%" align="left">   </td> </tr> <tr> <td style="border-bottom: black 6px double " valign="bottom" width="76%" align="left"> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left"> Stock options that had exercise prices greater than the average market price of our </div> <div style="display: block; text-indent: -9pt; margin-left: 9pt; MARGIN-RIGHT: 0pt" align="left">  common stock issuable under employee compensation plans(a) </div> </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 290 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> <td style="border-bottom: black 6px double " valign="bottom" width="9%" align="right"> 366 </td> <td style="border-bottom: black 6px double " valign="bottom" width="1%" align="left">   </td> </tr> </table> </div> <div align="left"> <table width="100%" cellspacing="0" cellpadding="0" border="0" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="width: 36pt" width="2%"> <div style="text-indent: 0pt; margin-left: 0pt; MARGIN-RIGHT: 0pt"> (a) </div> </td> <td width="98%"> <div align="left"> These common stock equivalents were outstanding during the first quarters of 2011 and 2010, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect. </div> </td> </tr> </table> </div> </div> </div>Basic and diluted earnings per share (EPS) were computed using the following data: falsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaTabular disclosure of an entity's basic and diluted earnings per share calculations.No authoritative reference available.falsefalseSchedule Of Earnings Per Share Basic By Common Class And Schedule Of Earnings Per Share Diluted By Common Class [Text Block]12Earnings Per Share Attributable to Common Shareholders (Table)UnKnownUnKnownUnKnownUnKnownfalsetrue